Evolve Adolescent Behavioral Health: Company Profile

Background

Overview

Evolve Adolescent Behavioral Health, established in 2014, is a leading provider of mental health and substance use treatment services for adolescents aged 12 to 17. Headquartered in Los Angeles, California, the company operates multiple facilities across the state, offering a range of programs designed to address the unique needs of each adolescent.

Mission and Vision

Evolve's mission is to empower teens and their families to heal, hope, and become the best versions of themselves. The organization is dedicated to providing compassionate, evidence-based care that fosters personal growth and resilience among adolescents facing mental health and substance use challenges.

Primary Area of Focus

The company specializes in treating a variety of adolescent mental health issues, including depression, anxiety, trauma, and substance use disorders. Evolve offers a continuum of care that encompasses residential treatment, partial hospitalization, intensive outpatient programs, and virtual outpatient services.

Industry Significance

Evolve plays a crucial role in addressing the growing adolescent mental health crisis in the United States. By providing specialized, evidence-based treatment options, the company contributes significantly to improving the well-being and future prospects of young individuals facing mental health and substance use challenges.

Key Strategic Focus

Core Objectives

Evolve aims to deliver high-quality, individualized care that leads to meaningful improvements in adolescents' mental health and overall quality of life. The organization focuses on creating a supportive environment that promotes healing, personal growth, and family involvement.

Specific Areas of Specialization

The company specializes in treating adolescents with mental health issues such as depression, anxiety, trauma, and substance use disorders. Evolve's programs are tailored to meet the developmental and emotional needs of teens, ensuring age-appropriate and effective interventions.

Key Technologies Utilized

Evolve employs evidence-based therapeutic modalities, including Dialectical Behavior Therapy (DBT), Cognitive Behavioral Therapy (CBT), and Motivational Interviewing. These approaches are integrated into treatment plans to address the complex needs of adolescents.

Primary Markets or Conditions Targeted

The primary market consists of adolescents aged 12 to 17 experiencing mental health and substance use challenges. Evolve's services are designed to cater to the unique needs of this demographic, providing specialized care that addresses both individual and family dynamics.

Financials and Funding

Funding History

In January 2020, Evolve Treatment Centers was acquired by Galen Partners, a healthcare-focused growth equity investment firm. This acquisition aimed to expand Evolve's capacity to provide high-quality adolescent mental health treatment services.

Total Funds Raised

Specific details regarding the total funds raised by Evolve prior to the acquisition are not publicly disclosed.

Notable Investors

Galen Partners is the primary investor following the acquisition in 2020. Prior to this, detailed information about other investors is not publicly available.

Intended Utilization of Capital

The capital from the acquisition was intended to support the expansion of Evolve's services, enhance clinical programs, and increase access to adolescent mental health care across California.

Pipeline Development

Key Pipeline Candidates

Evolve's pipeline focuses on expanding its range of treatment programs and services to meet the evolving needs of adolescents facing mental health and substance use challenges.

Stages of Clinical Trials or Product Development

As a service provider, Evolve does not engage in clinical trials or product development. Instead, the organization continually refines and develops its therapeutic programs based on evidence-based practices and emerging research in adolescent mental health.

Target Conditions

The primary conditions targeted include depression, anxiety, trauma, and substance use disorders among adolescents.

Relevant Timelines for Anticipated Milestones

Specific timelines for program developments or expansions are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

Evolve utilizes proprietary therapeutic approaches, integrating DBT, CBT, and Motivational Interviewing into its treatment programs. These methodologies are tailored to address the specific needs of adolescents.

Significant Scientific Methods

The organization employs evidence-based scientific methods, including DBT skills training, to help teens build practical tools for emotion regulation, distress tolerance, interpersonal effectiveness, and mindfulness. Additionally, experiential therapies such as equine-assisted therapy, art therapy, music therapy, yoga, and fitness are incorporated to enhance treatment outcomes.

Leadership Team

Executive Profiles

• Michelle Gross: Chief Executive Officer. Michelle leads Evolve with a focus on clinical excellence and compassionate care.

• Alyson Orcena: Chief Clinical Officer. Alyson oversees clinical programs, ensuring they meet the highest standards of adolescent mental health care.

• Lisa Gold Faguet: Vice President of Operations. Lisa manages operational aspects, facilitating the smooth delivery of services across all facilities.

• Michael Anderson: Vice President, People Operations. Michael focuses on human resources, fostering a supportive and effective work environment.

• Kara Gross: Director of Marketing. Kara leads marketing initiatives to promote Evolve's services and mission.